Octreotide Injection Generics - Manufacturers & Suppliers
Sandostatin.(EU & US)
| Product/Composition:- | Octreotide Injection |
|---|---|
| Strength:- | 50 mcg/mL, 100 mcg/mL, 200,cg/mL, 500 mcg/mL |
| Form:- | Injection |
| Reference Brands:- | Sandostatin.(EU & US) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Octreotide Injection (50 mcg/mL, 100 mcg/mL, 200 mcg/mL, 500 mcg/mL) is used in oncology to manage symptoms and control growth in carcinoid tumors, gastroenteropancreatic neuroendocrine tumors (GEP-NETs), and acromegaly. Available in both U.S. and EU, this somatostatin analog is administered via subcutaneous or IV injection. It helps regulate hormone secretion, improving symptoms and tumor control in oncology patients, making it a key product in oncology B2B distribution.
Octreotide Injection 50 mcg/mL, 100 mcg/mL, 200 mcg/mL, and 500 mcg/mL is used to manage symptoms and control the growth of neuroendocrine tumors in oncology. Primarily indicated for carcinoid tumors, GEP-NETs, and acromegaly, Octreotide works by mimicking the effects of somatostatin, regulating hormone production. It is available in subcutaneous or IV formulations and is a vital part of oncology B2B distribution in both the U.S. and EU, ensuring better symptom management and tumor control for patients suffering from neuroendocrine malignancies and related conditions.